Your browser doesn't support javascript.
loading
Spiro-Oxindole Skeleton Compounds Are Efficient Inhibitors for Indoleamine 2,3-Dioxygenase 1: An Attractive Target for Tumor Immunotherapy.
Yan, Daojing; Xu, Jiakun; Wang, Xiang; Zhang, Jiaxing; Zhao, Gang; Lin, Yingwu; Tan, Xiangshi.
Afiliación
  • Yan D; Department of Chemistry, Fudan University, 2005 Songhu Road, Shanghai 200433, China.
  • Xu J; Key Laboratory of Sustainable Development of Polar Fisheries, Ministry of Agriculture and Rural Affairs, Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Laboratory for Marine Drugs and Byproducts of Pilot National Laboratory for Marine Science and Technology, Qingdao 26
  • Wang X; Department of Chemistry, Fudan University, 2005 Songhu Road, Shanghai 200433, China.
  • Zhang J; Key Laboratory of Synthetic Chemistry of Natural Substances, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, China.
  • Zhao G; Key Laboratory of Synthetic Chemistry of Natural Substances, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, China.
  • Lin Y; School of Chemistry and Chemical Engineering, University of South China, Hengyang 421001, China.
  • Tan X; Department of Chemistry, Fudan University, 2005 Songhu Road, Shanghai 200433, China.
Int J Mol Sci ; 23(9)2022 Apr 23.
Article en En | MEDLINE | ID: mdl-35563059
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Compuestos de Espiro / Inhibidores Enzimáticos / Indolamina-Pirrol 2,3,-Dioxigenasa / Oxindoles Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Compuestos de Espiro / Inhibidores Enzimáticos / Indolamina-Pirrol 2,3,-Dioxigenasa / Oxindoles Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article País de afiliación: China